Sociedad Americana de Hirudoterapia

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea

Research article published in Zootaxa (2024)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Preclinical (animal)Desarrollo de fármacosSawyer RT et al. · Zootaxa, 2024

Abstract

This is a twelve-year longitudinal study of a common snail-feeding leech indigenous to the Albemarle region of northeastern North Carolina, USA. Based on contents of this paper the species is provisionally identified as Helobdella lineata (Verrill, 1874). For all practical purposes this is the first comprehensive description of this species. Particular attention is focused on variability of its dorsal papillae and variable pigment patterns within the Albemarle population. A total of 404 specimens were collected from 25 collecting stations in disparate parts of the region. Specialised leech traps set in these swamps were monitored regularly yielding unprecedented information on its morphology, ecology and general biology. This study recognises four principal pigment variants within the Albemarle region which, based on dissections, appear to represent a single biological species. Moreover, limited observations suggest that pigment variability is attributable primarily to adaptive camouflage to local surroundings. Methodologically it is emphasized in this paper that variable traits cannot serve as key taxonomic anchors. A proposed alternative diagnosis for identifying H. lineata is based entirely on more rigorous, non-variable characters. A significant finding is that H. lineata is most meaningfully understood in terms of specialist adaptation to feeding on snails. Furthermore, it is proposed that such adaptation required a major evolutionary shift within the foregut of this species. Evidence is presented that H. lineata uses uniquely large salivary cells to dissolves solid snail tissue into a semi-fluid state before ingestion via a specialised proboscis. This is the first example of extra-oral digestion in the Hirudinea.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsLeechesNorth CarolinaSnailsFemaleAnimal StructuresAnimal DistributionFeeding BehaviorMaleBody SizeEcosystemOrgan Size

Resumen

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea.

Por qué esto importa para la hirudoterapia

Este estudio longitudinal de doce años examinó la biología, morfología y taxonomía de una sanguijula que se alimenta de caracoles en Carolina del Norte, identificada provisionalmente como Helobdella lineata. Los investigadores proporcionaron una descripción exhaustiva de la especie y presentaron la primera evidencia de digestión extraoral en Hirudinea, señalando que la sanguijula utiliza células salivares excepcionalmente grandes para disolver el tejido sólido del caracol hasta un estado semifluido antes de la ingestión. Si bien esto destaca el potencial bioquímico digestivo de las secreciones salivares de la sanguijula, su relevancia para la ASH es altamente indirecta. El estudio es puramente taxonómico y ecológico, se centra en una especie de sanguijula no hematófaga y no aporta conocimientos aplicables sobre la hirudoterapia en humanos ni sobre las propiedades médicas de la saliva de las sanguijuelas hematófagas.

Citación

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea

Sawyer RT et al. · Zootaxa, 2024

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.